Joseph Thome
Stock Analyst at TD Cowen
(4.82)
# 346
Out of 4,362 analysts
390
Total ratings
55.5%
Success rate
20.3%
Average return
Main Sectors:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Maintained: Buy | $255 → $275 | $233.49 | +17.78% | 33 | Jun 3, 2026 | |
| CSE: DRUG Bright Minds Biosciences Inc. | Maintained: Buy | n/a | $106.00 | - | 8 | May 20, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $660 → $675 | $549.47 | +22.85% | 28 | May 17, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | n/a | $28.34 | - | 2 | May 14, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $75 | $51.24 | +46.37% | 23 | May 13, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Buy | n/a | $13.02 | - | 20 | May 11, 2026 | |
| MGX Metagenomi Therapeutics | Maintained: Buy | n/a | $1.34 | - | 12 | May 11, 2026 | |
| PTCT PTC Therapeutics | Upgraded: Buy | $75 → $90 | $68.68 | +31.04% | 46 | May 8, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | n/a | $19.66 | - | 4 | May 8, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | n/a | $53.44 | - | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $145 | $91.95 | +57.69% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.58 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.14 | - | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.00 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $42 | $42.76 | -1.78% | 18 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $72.55 | - | 6 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $275 | $230.93 | +19.08% | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.88 | - | 24 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.35 | - | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.20 | - | 6 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.42 | +139.85% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.17 | - | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.59 | n/a | 9 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.14 | n/a | 6 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $139.72 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.66 | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $115.42 | n/a | 1 | Oct 1, 2020 |
Axsome Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $255 → $275
Current: $233.49
Upside: +17.78%
Bright Minds Biosciences Inc.
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $106.00
Upside: -
United Therapeutics
May 17, 2026
Maintained: Buy
Price Target: $660 → $675
Current: $549.47
Upside: +22.85%
MapLight Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $28.34
Upside: -
AnaptysBio
May 13, 2026
Maintained: Buy
Price Target: $75
Current: $51.24
Upside: +46.37%
Intellia Therapeutics
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $13.02
Upside: -
Metagenomi Therapeutics
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1.34
Upside: -
PTC Therapeutics
May 8, 2026
Upgraded: Buy
Price Target: $75 → $90
Current: $68.68
Upside: +31.04%
Denali Therapeutics
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $19.66
Upside: -
Xenon Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $53.44
Upside: -
May 7, 2026
Rated: Buy
Price Target: $125 → $145
Current: $91.95
Upside: +57.69%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $6.58
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $3.14
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $37.00
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $40 → $42
Current: $42.76
Upside: -1.78%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $72.55
Upside: -
May 5, 2026
Rated: Buy
Price Target: $220 → $275
Current: $230.93
Upside: +19.08%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $29.88
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $16.35
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $13.20
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: $13
Current: $5.42
Upside: +139.85%
Nov 5, 2025
Maintained: Buy
Price Target: n/a
Current: $7.17
Upside: -
Jul 19, 2024
Rated: Hold
Price Target: n/a
Current: $17.59
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $3.14
Upside: n/a
Oct 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 24, 2023
Maintained: Hold
Price Target: $40
Current: $139.72
Upside: n/a
Oct 10, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $14.66
Upside: n/a
Oct 1, 2020
Reiterated: Buy
Price Target: n/a
Current: $115.42
Upside: n/a